Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results. (18th October 2021)
- Record Type:
- Journal Article
- Title:
- Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results. (18th October 2021)
- Main Title:
- Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results
- Authors:
- Yamaguchi, Hirokazu
Sato, Masaaki
Yamamoto, Kazumichi
Ueda, Keiko
Date, Hiroshi
Chen-Yoshikawa, Toyofumi
Yamada, Yoshito
Tokuno, Junko
Yanagiya, Masahiro
Kojima, Fumitsugu
Yoshiyasu, Nobuyuki
Kobayashi, Masashi
Nakashima, Yasuhiro
Koike, Terumoto
Sakamoto, Jin
Kosaka, Shinji
Fukai, Ryuta
Nishida, Tomoki
Sakai, Hiroaki
Shinohara, Shinji
Takenaka, Masaru
Tanaka, Fumihiro
Misawa, Kenji
Nakajima, Jun - Abstract:
- Abstract: OBJECTIVES: The short-term efficacy of virtual-assisted lung mapping (VAL-MAP), a preoperative bronchoscopic multi-spot lung-marking technique, has been confirmed in 2 prospective multicentre studies. The objectives of this study were to analyse the local recurrence and survival of patients enrolled in these studies, long-term. METHODS: Of the 663 patients enrolled in the 2 studies, 559 patients' follow-up data were collected. After excluding those who did not undergo VAL-MAP, whose resection was not for curative intent, who underwent concurrent resection without VAL-MAP, or who eventually underwent lobectomy instead of sublobar resection (i.e. wedge resection or segmentectomy), 422 patients were further analysed. RESULTS: Among 264 patients with primary lung cancer, the 5-year local recurrence-free rate was 98.4%, and the 5-year overall survival (OS) rate was 94.5%. Limited to stage IA2 or less (≤2 cm in diameter; n = 238, 90.1%), the 5-year local recurrence-free and OS rates were 98.7% and 94.8%, respectively. Among 102 patients with metastatic lung tumours, the 5-year local recurrence-free rate was 93.8% and the 5-year OS rate was 81.8%. Limited to the most common (colorectal) cancer ( n = 53), the 5-year local recurrence-free and OS rates were 94.9% and 82.3%, respectively. CONCLUSIONS: VAL-MAP, which is beneficial in localizing small barely palpable pulmonary lesions and determining the appropriate resection lines, was associated with reasonable long-termAbstract: OBJECTIVES: The short-term efficacy of virtual-assisted lung mapping (VAL-MAP), a preoperative bronchoscopic multi-spot lung-marking technique, has been confirmed in 2 prospective multicentre studies. The objectives of this study were to analyse the local recurrence and survival of patients enrolled in these studies, long-term. METHODS: Of the 663 patients enrolled in the 2 studies, 559 patients' follow-up data were collected. After excluding those who did not undergo VAL-MAP, whose resection was not for curative intent, who underwent concurrent resection without VAL-MAP, or who eventually underwent lobectomy instead of sublobar resection (i.e. wedge resection or segmentectomy), 422 patients were further analysed. RESULTS: Among 264 patients with primary lung cancer, the 5-year local recurrence-free rate was 98.4%, and the 5-year overall survival (OS) rate was 94.5%. Limited to stage IA2 or less (≤2 cm in diameter; n = 238, 90.1%), the 5-year local recurrence-free and OS rates were 98.7% and 94.8%, respectively. Among 102 patients with metastatic lung tumours, the 5-year local recurrence-free rate was 93.8% and the 5-year OS rate was 81.8%. Limited to the most common (colorectal) cancer ( n = 53), the 5-year local recurrence-free and OS rates were 94.9% and 82.3%, respectively. CONCLUSIONS: VAL-MAP, which is beneficial in localizing small barely palpable pulmonary lesions and determining the appropriate resection lines, was associated with reasonable long-term outcomes. Subj collection: 152, 1542 Abstract : Suspicious small pulmonary nodules are being found more often, with the development and widespread use of high-resolution computed tomography (CT). … (more)
- Is Part Of:
- European journal of cardio-thoracic surgery. Volume 61:Number 4(2022)
- Journal:
- European journal of cardio-thoracic surgery
- Issue:
- Volume 61:Number 4(2022)
- Issue Display:
- Volume 61, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 61
- Issue:
- 4
- Issue Sort Value:
- 2022-0061-0004-0000
- Page Start:
- 761
- Page End:
- 768
- Publication Date:
- 2021-10-18
- Subjects:
- Bronchoscopy -- Localization -- Lung cancer -- Metastatic lung tumour -- Ground-glass opacity
Heart -- Surgery -- Periodicals
Chest -- Surgery -- Periodicals
617.54 - Journal URLs:
- http://ejcts.oxfordjournals.org/ ↗
http://www.sciencedirect.com/science/journal/10107940 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/ejcts/ezab421 ↗
- Languages:
- English
- ISSNs:
- 1010-7940
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725620
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21197.xml